3-疏基吡啶-4-羧酸 | 18103-75-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 3-疏基吡啶-4-羧酸
• 英文名称: 3-mercaptoisonicotinic acid
• 英文别名: 3-Mercapto-isonicotinsaeure；3-sulfanylpyridine-4-carboxylic acid
• CAS: 18103-75-8
• 化学式: C₆H₅NO₂S
• 分子量: 155.177
• InChiKey: FRRCVAYPJRENEV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  51.2
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  3-疏基吡啶-4-羧酸 在 tetraphosphorus decasulfide 、 mercury(II) diacetate 、 碘 、 碳酸氢钠 作用下， 以 吡啶 、 乙醇 、 氯仿 、 溶剂黄146 为溶剂， 反应 74.0h， 生成 2-(2-piperidin-1-yl-ethyl)-isothiazolo[5,4-c]pyridin-3-one
  参考文献：
  名称：

  Baggaley, Keith H.; Jennings, L. John A.; Tyrrell, A. William R., Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 1393 - 1396

  摘要：

  DOI：
• 作为产物：
  描述：

  3-氨基-4-吡啶羧酸 在 盐酸 、 sodium hydroxide 、 Na2ξ 作用下， 生成 3,3'-disulfanediyl-di-isonicotinic acid 、 3-疏基吡啶-4-羧酸
  参考文献：
  名称：

  Sucharda; Troszkiewiczowna, Roczniki Chemii, 1932, vol. 12, p. 493,495

  摘要：

  DOI：

文献信息

• [EN] HEPATITIS B CORE PROTEIN MODULATORS<br/>[FR] MODULATEURS DES PROTÉINES DU NOYAU DE L'HÉPATITE B
  申请人：ASSEMBLY BIOSCIENCES INC

  公开号：WO2018053157A1

  公开（公告）日：2018-03-22

  The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula:

  本公开提供了部分具有对乙型肝炎病毒Cp的变构效应物性的化合物。本文还提供了治疗病毒感染（如乙型肝炎）的方法，包括向需要的患者施用公开的化合物的公式：
• 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
  申请人：Essential Therapeutics, Inc.

  公开号：US06723716B1

  公开（公告）日：2004-04-20

  The present invention relates to a cephem prodrug having formula III or formula IV: or a pharmaceutically acceptable salt thereof, wherein R′1 is selected from the group consisting of hydrogen and —C(O)CH(NH2)CH3 and R′2 is selected from the group consisting of hydrogen and an acyl group that is cleaved by an enzyme found in mammals, with the proviso that, when either R′1 or R′2 is hydrogen, the other is not. A, B, L, G, E, and J are each independently nitrogen or carbon such that the respective rings are selected from the group consisting of provided that the group —CH2—S—CH2CH2NHR′2 is attached only to a carbon atom of said heterocyclic group, and Q is selected from the group consisting of nitrogen and —CX, wherein X is selected from the group consisting of hydrogen and chlorine.

  本发明涉及具有III式或IV式的头孢菌素前药：或其药用可接受的盐，其中R′1选自由氢和—C(O)CH(NH2)CH3的群组，R′2选自由氢和在哺乳动物中发现的一种酶可水解的酰基团，但条件是当R′1或R′2中的一个是氢时，另一个不是。A、B、L、G、E和J分别独立地为氮或碳，使得相应的环被选自的群组选中，前提是群组—CH2—S—CH2CH2NHR′2仅连接到所述杂环基团的一个碳原子上，Q选自氮和—CX的群组，其中X选自氢和氯。
• Cephalosporin antibiotics
  申请人：Microcide Pharmaceuticals, Inc.

  公开号：US06030965A1

  公开（公告）日：2000-02-29

  The present invention includes novel compounds of formula where A, B, D, and E are selected from the group consisting of carbon, nitrogen and sulfur, R.sup.99 is selected from the group consisting of sulfur, SO, S0.sub.2, NH, N-alkyl, oxygen, C.dbd.C (cis or trans), and C.tbd.C, and R.sup.12 is NR.sup.13 R.sup.14, ##STR1## The invention also includes the pharmacologically acceptable salts which exhibit antibiotic activity against a wide spectrum of organisms including organisms which are resistant to .beta.-lactam antibiotics and are useful as antibacterial agents. The invention also relates to novel intermediates useful for making the novel compounds of the present invention and to novel methods for producing the novel compounds and intermediate compounds.

  本发明包括以下式的新化合物，其中A、B、D和E选自碳、氮和硫组成的群体，R.sup.99选自硫、SO、SO.sub.2、NH、N-烷基、氧、C.dbd.C（顺式或反式）和C.tbd.C，R.sup.12为NR.sup.13 R.sup.14，本发明还包括表现出抗生素活性的药理学上可接受的盐，对包括对β-内酰胺抗生素具有抗性的广泛范围的生物体具有抗生素活性，并且可用作抗菌剂。本发明还涉及用于制备本发明新化合物的新中间体以及用于生产新化合物和中间化合物的新方法。
• CHEMICALLY AMPLIFIED POSITIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM, METHOD OF MANUFACTURING PHOTOSENSITIVE DRY FILM, METHOD OF MANUFACTURING PATTERNED RESIST FILM, METHOD OF MANUFACTURING SUBSTRATE WITH TEMPLATE, METHOD OF MANUFACTURING PLATED ARTICLE, AND MERCAPTO COMPOUND
  申请人：TOKYO OHKA KOGYO CO., LTD.

  公开号：US20190121233A1

  公开（公告）日：2019-04-25

  A chemically amplified positive-type photosensitive resin composition capable of suppressing the occurrence of “footing” in which the width of the bottom (the side proximal to the surface of a support) becomes narrower than that of the top (the side proximal to the surface of a resist layer) in the nonresist portion; and the generation of development residue when a resist pattern serving as a template for a plated article is formed on a metal surface of a substrate using the photosensitive resin composition. A mercapto compound having a specific structure is included in the photosensitive resin composition, and includes an acid generator which generates acid upon exposure to an irradiated active ray or radiation, and a resin whose solubility in alkali increases under the action of acid.

  一种化学增感型正型光敏树脂组合物，能够抑制“足部”现象的发生，即底部（靠近支撑表面的一侧）的宽度变窄，小于顶部（靠近抗蚀层表面的一侧）的宽度，同时在使用该光敏树脂组合物在基板的金属表面上形成用作电镀物品模板的抗蚀图案时，能够减少残留物的产生。该光敏树脂组合物中包含一种具有特定结构的巯基化合物，其中包括一个酸发生剂，该酸发生剂在暴露于辐射活性光线或辐射时产生酸，以及一种树脂，在酸的作用下其在碱性溶液中的溶解度增加。
• AZA-benzothiophenyl compounds and methods of use
  申请人：Savy Pierre Pascal

  公开号：US20080081821A1

  公开（公告）日：2008-04-03

  The invention relates to azabenzothiophenyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to azabenzothiophenyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

  本发明涉及一种具有抗癌和/或抗炎活性的Formula I的氮杂苯并噻吩化合物，更具体地，涉及一种抑制MEK激酶活性的氮杂苯并噻吩化合物。本发明提供了用于抑制异常细胞生长或治疗哺乳动物的增殖性疾病或治疗炎症性疾病的组合物和方法。本发明还涉及使用该化合物进行哺乳动物细胞的体外、原位和体内诊断或治疗，或相关病理条件的方法。